Literature DB >> 19919161

Structural basis of the inhibition of class A beta-lactamases and penicillin-binding proteins by 6-beta-iodopenicillanate.

Eric Sauvage1, Astrid Zervosen, Georges Dive, Raphael Herman, Ana Amoroso, Bernard Joris, Eveline Fonzé, Rex F Pratt, André Luxen, Paulette Charlier, Frédéric Kerff.   

Abstract

6-Beta-halogenopenicillanates are powerful, irreversible inhibitors of various beta-lactamases and penicillin-binding proteins. Upon acylation of these enzymes, the inhibitors are thought to undergo a structural rearrangement associated with the departure of the iodide and formation of a dihydrothiazine ring, but, to date, no structural evidence has proven this. 6-Beta-iodopenicillanic acid (BIP) is shown here to be an active antibiotic against various bacterial strains and an effective inhibitor of the class A beta-lactamase of Bacillus subtilis BS3 (BS3) and the D,D-peptidase of Actinomadura R39 (R39). Crystals of BS3 and of R39 were soaked with a solution of BIP and their structures solved at 1.65 and 2.2 A, respectively. The beta-lactam and the thiazolidine rings of BIP are indeed found to be fused into a dihydrothiazine ring that can adopt two stable conformations at these active sites. The rearranged BIP is observed in one conformation in the BS3 active site and in two monomers of the asymmetric unit of R39, and is observed in the other conformation in the other two monomers of the asymmetric unit of R39. The BS3 structure reveals a new mode of carboxylate interaction with a class A beta-lactamase active site that should be of interest in future inhibitor design.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19919161      PMCID: PMC2896319          DOI: 10.1021/ja9051526

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  44 in total

1.  Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus.

Authors:  C Reading; M Cole
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

2.  Unexpected influence of a C-terminal-fused His-tag on the processing of an enzyme and on the kinetic and folding parameters.

Authors:  P Ledent; C Duez; M Vanhove; A Lejeune; E Fonzé; P Charlier; F Rhazi-Filali; I Thamm; G Guillaume; B Samyn; B Devreese; J Van Beeumen; J Lamotte-Brasseur; J M Frère
Journal:  FEBS Lett       Date:  1997-08-18       Impact factor: 4.124

3.  Automated analysis of enzyme inactivation phenomena. Application to beta-lactamases and DD-peptidases.

Authors:  F De Meester; B Joris; G Reckinger; C Bellefroid-Bourguignon; J M Frère; S G Waley
Journal:  Biochem Pharmacol       Date:  1987-07-15       Impact factor: 5.858

4.  6 beta-Bromopenicillanic acid inactivates beta-lactamase I.

Authors:  V Knott-Hunziker; B S Orlek; P G Sammes; S G Waley
Journal:  Biochem J       Date:  1979-01-01       Impact factor: 3.857

5.  Susceptibility of Escherichia coli isolates with TEM-1 beta-lactamase to combinations of BRL42715, tazobactam or clavulanate with piperacillin or amoxycillin .

Authors:  D M Livermore; P Seetulsingh
Journal:  J Antimicrob Chemother       Date:  1991-06       Impact factor: 5.790

6.  Crystal structures of the Bacillus licheniformis BS3 class A beta-lactamase and of the acyl-enzyme adduct formed with cefoxitin.

Authors:  Eveline Fonzé; Marc Vanhove; Georges Dive; Eric Sauvage; Jean-Marie Frère; Paulette Charlier
Journal:  Biochemistry       Date:  2002-02-12       Impact factor: 3.162

7.  Primary and predicted secondary structures of the Actinomadura R39 extracellular DD-peptidase, a penicillin-binding protein (PBP) related to the Escherichia coli PBP4.

Authors:  B Granier; C Duez; S Lepage; S Englebert; J Dusart; O Dideberg; J Van Beeumen; J M Frère; J M Ghuysen
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

8.  Crystal structure of the Actinomadura R39 DD-peptidase reveals new domains in penicillin-binding proteins.

Authors:  Eric Sauvage; Raphaël Herman; Stephanie Petrella; Colette Duez; Fabrice Bouillenne; Jean-Marie Frère; Paulette Charlier
Journal:  J Biol Chem       Date:  2005-06-29       Impact factor: 5.157

9.  Lactivicin, a naturally occurring non-beta-lactam antibiotic having beta-lactam-like action: biological activities and mode of action.

Authors:  Y Nozaki; N Katayama; S Harada; H Ono; H Okazaki
Journal:  J Antibiot (Tokyo)       Date:  1989-01       Impact factor: 2.649

Review 10.  The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis.

Authors:  Eric Sauvage; Frédéric Kerff; Mohammed Terrak; Juan A Ayala; Paulette Charlier
Journal:  FEMS Microbiol Rev       Date:  2008-02-11       Impact factor: 16.408

View more
  5 in total

1.  Inhibition of Streptococcus pneumoniae penicillin-binding protein 2x and Actinomadura R39 DD-peptidase activities by ceftaroline.

Authors:  Astrid Zervosen; André Zapun; Jean-Marie Frère
Journal:  Antimicrob Agents Chemother       Date:  2012-11-12       Impact factor: 5.191

Review 2.  Current challenges in antimicrobial chemotherapy: focus on ß-lactamase inhibition.

Authors:  Carine Bebrone; Patricia Lassaux; Lionel Vercheval; Jean-Sébastien Sohier; Adrien Jehaes; Eric Sauvage; Moreno Galleni
Journal:  Drugs       Date:  2010-04-16       Impact factor: 9.546

3.  Substrate selectivity and a novel role in inhibitor discrimination by residue 237 in the KPC-2 beta-lactamase.

Authors:  Krisztina M Papp-Wallace; Magdalena Taracila; John M Hornick; Andrea M Hujer; Kristine M Hujer; Anne M Distler; Andrea Endimiani; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2010-04-26       Impact factor: 5.191

4.  Penicillin Derivatives Inhibit the SARS-CoV-2 Main Protease by Reaction with Its Nucleophilic Cysteine.

Authors:  Tika R Malla; Lennart Brewitz; Dorian-Gabriel Muntean; Hiba Aslam; C David Owen; Eidarus Salah; Anthony Tumber; Petra Lukacik; Claire Strain-Damerell; Halina Mikolajek; Martin A Walsh; Christopher J Schofield
Journal:  J Med Chem       Date:  2022-05-12       Impact factor: 8.039

Review 5.  Development of new drugs for an old target: the penicillin binding proteins.

Authors:  Astrid Zervosen; Eric Sauvage; Jean-Marie Frère; Paulette Charlier; André Luxen
Journal:  Molecules       Date:  2012-10-24       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.